Oncology & Cancer

Breakthrough discovery to transform prostate cancer treatment

A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University ...

Oncology & Cancer

New recommendations on genetic testing for prostate cancer

Prostate cancer is a leading cause of death from cancer in the US and especially in the Philadelphia region. Consistently, Philadelphia has outpaced the state of PA and the nation in diagnoses and death from prostate cancer. ...

Oncology & Cancer

Loss of lipid-regulating gene fuels prostate cancer spread

Johns Hopkins Kimmel Cancer Center researchers from the Department of Radiation Oncology and Molecular Radiation Sciences identified a lipid-regulating protein that conveys what the researchers describe as "superpowers" onto ...

Oncology & Cancer

A different Chia-PET provides insight into prostate cancer

UT Southwestern researchers have identified vast webs of small snippets of the genome that interact with each other and with genes to promote prostate cancer. Their findings, published June 22 in the Journal of Clinical Investigation, ...

page 1 from 2